AVANIR Reports Third Quarter Fiscal 2007 Financial Results.
Business Wire › August 08, 2007
Linked as:
Extract
AVANIR Reports Third Quarter Fiscal 2007 Financial Results.
Announces Progress on Zenvia Clinical Programs
ALISO VIEJO, Calif. -- AVANIR Pharmaceuticals (NASDAQ:AVNR) today reported financial results for the three and nine months ended June 30, 2007. For the third fiscal quarter of 2007, AVANIR reported a net loss of $9.2 million, or $0.23 per share, compared with a net loss of $17.6 million, or $0.56 per share, for the comparable quarter in 2006. Revenues for the third quarter of fiscal 2007 were $7.1 million, compared with $2.4 million for the third quarter of fiscal 2006. Revenues in the third quarter of fiscal 2007 included FazaClo[R] net revenues of $4.9 million....See the full content of this document
Sponsored links
